STILL SEEKING OUTCOMES AFTER 6TH STOMA APPLIANCE SCHEME SCHEDULE REVIEW:
LOWER QUALITY OF LIFE AND OTHER HEALTH IMPACTS EXPERIENCED BY OSTOMATES
Matt Dalton
Chair, Stoma Industry Association
SEGMENT RELEASE
Filmed in Sydney, New South Wales | December 2024
A stoma is a surgically created opening in the abdomen to remove body waste, such as faeces and urine. Many conditions can require a stoma, including colorectal cancer, inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis, bladder cancer, injury trauma, and congenital defects.
50,000 Australians have undergone the trauma and challenge of having a stoma inserted. Whilst the Australian Government invests in the appliances and products they need through the Stoma Appliance Scheme (SAS), this list is dated and doesn’t include as many of the products available in other countries. A new report commissioned by the Stoma Industry Association (SIA) shows Australia lagging countries such as the United Kingdom, Canada and Spain in supporting ostomates (people with a stoma).
The report found that the Quality of Life (QoL) for Australian ostomates is lower than other developed nations and the general community. The reason for this includes:
- Australia reimburses fewer products on the Stoma Appliance Scheme (SAS). The UK provides 60 per cent more, for example.
- Australian spending as a percentage of GDP is five times smaller than Canada, and three times smaller than the UK.
- There are fewer specialist nurses to support the patient population. According to the Australian Association of Stomal Therapy Nurses, “A Stomal Therapy Nurse (STN) specialises in the management of patients with faecal and urinary diversions. In addition, the STN is an expert in the management of difficult and draining wounds, fistulae, gastrostomies, acute and chronic wounds and associated skin care. In short, STNs can assist with advice and management of any stoma and wound issue, and may also provide continence advice.”
The report also details the daily challenges of Australian ostomates:
- 1 in 5 stoma patients isolate themselves from others
- 65 per cent of patients say their ability to work is negatively impacted
- 3 in 5 patients experience a reduction in intimacy
Stoma appliances and supporting products are subsidised by the Commonwealth funded scheme.
There have been five reviews of the SAS, none of which have been released. The current (sixth) review released earlier this year by the Australian Government.
Australian Health Journal spoke with the Stoma Industry Association Chair, Matt Dalton about the same access to products needed by 50,000 Australian ostomates and the quality of life as patients overseas.
You Might also like
-
Targeted National Lung Cancer Screening Program commences in 2025
In February 2025, Australian Health Journal spoke with Mark Brooke, Chief Executive Officer of Lung Foundation Australia, at the 10th Australian Lung Cancer Conference in Adelaide, on the upcoming commencement of the National Lung Cancer Screening Program (NLCSP)
-
Thyroid health into pregnancy
‘Without an adequate amount of thyroid hormone mothers can be exposed to hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia or eclampsia, which affect around 10% of pregnant women and are the leading causes of maternal and neonatal mortality worldwide. Mothers who suffer from hypertensive disorders during pregnancy are at increased risk of long-term cardiovascular consequences and hypertensive disorders in subsequent pregnancies. Evidence also indicates a risk of reduced cognitive ability to their offspring.
‘Knowing if you are genetically predisposed to Hashimoto’s or Graves’ Diseases, which are both thyroid autoimmune disorders is important to be aware of, to ensure all appropriate tests are ordered. Autoimmune disorders may predispose mothers to a thyroid problem during pregnancy’, says Professor Creswell Eastman, who also serves as the ATF’s Principal Medical Advisor.
-
Harnessing the skillset and availability of the nation’s Exercise Physiologists and Scientists
Katie Lyndon MBA, BAppSci, ESSAF, FACHSM, CHE, AEP, AES, GAICD, CHIA, is an allied health professional and executive leader with nearly two decades of experience spanning executive leadership, delivery of strategic programs across the health system and clinical care.
As CEO of Exercise & Sports Science Australia (ESSA), Katie brings a unique blend of frontline experience and strategic vision to advance the profession and advocate for evidence-based exercise in preventive health and chronic disease management. Her long-standing commitment to ESSA includes serving as Board Vice President, Policy and Advocacy Manager, Standards Council member and ESSA Fellow.